Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 4 of 4 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Etanercepet, rituximab, abatacept, tocilizumab, sarilumab | 4件: Abatacept Abatacept,Rituximab, Sarilumab (Sarilumab), Tocilizumab | 4件: Tocilizumab
Tocilizumab
,Rituximab , Abatacept , Sarilumab (Sarilumab, Sarilumab) 💬 1. Etanercepet, rituximab, abatacept, tocilizumab, sarilumab
| 4件: CD80 CD80,CD86, IL6R, MS4A1 💬 | 24件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - ... | 1件: 46 46 💬1. Etanercepet, rituximab, abatacept, tocilizumab, sarilumab
| ||||||||||||||||
| 2 | Sarilumab | 1件: Sarilumab Sarilumab (Sarilumab) | 1件: Sarilumab
Sarilumab
(Sarilumab, Sarilumab) 💬2. Sarilumab
| 1件: IL6R IL6R 💬2. Sarilumab
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway ... | 5件: 41 41, 46, 84, 107, 271 💬
| ||||||||||||||||
| 3 | Sarilumab SAR153191 | 1件: Sarilumab Sarilumab (Sarilumab) | 1件: Sarilumab
Sarilumab
(Sarilumab, Sarilumab) 💬3. Sarilumab SAR153191
| 1件: IL6R IL6R 💬3. Sarilumab SAR153191
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway ... | 1件: 41 41 💬3. Sarilumab SAR153191
| ||||||||||||||||
| 4 | Tocilizumab or sarilumab | 2件: Sarilumab Sarilumab (Sarilumab),Tocilizumab | 2件: Tocilizumab
Tocilizumab
,Sarilumab (Sarilumab, Sarilumab) 💬 4. Tocilizumab or sarilumab
| 1件: IL6R IL6R 💬4. Tocilizumab or sarilumab
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway ... | 1件: 46 46 💬4. Tocilizumab or sarilumab
|